The sphk1/S1PR3/pbx1 axis plays a crucial role in regulating the cell cycle of NSCLC, and targeting sphk1 could offer therapeutic benefits in tumor treatment [37]. This evidence concerns the gene SPHK1 and non-small cell lung carcinoma.